nScrypt and taking bioprinting to the field

Part V of our exclusive series on exciting applications in bioprinting today

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future—what it could do—we want to look at what is happening now in the field that is exciting.

As part of our Medical AM Focus, we asked bioprinting leaders from across the sector what they consider to be the most exciting application for their bioprinting technologies today. In this segment, we hear from Florida-based bioprinting company nScrypt.

Founded in 2002 as a spin-off of medtech company Sciperio, Orlando-based nScrypt is a boundary pushing bioprinting company, to say the least. The company, which has developed a precision microdispensing technology and direct digital manufacturing solutions, is one of a small handful of companies in the segment taking its bioprinting beyond the lab.

Last year, nScrypt partnered with the U.S. Military, the Uniformed Services University 4D Bio3 Program and The Geneva Foundation to deploy a ruggedized version of its BioAssembly Tool (BAT) bioprinter to an undisclosed desert location for point-of-care bioprinting. The ambitious project has to date resulted in the production of many medical devices printed in the field, including:

nScrypt bioprinting series

  • A 3D printed scalpel handle and hemostate
  • 3D bioprinted bioactive bandages made from a antibiotic-containing hydrogel layer and a 3D printed structural layer
  • A 3D printed surgical model of T9 vertebrae
  • A 3D bioprinted meniscus made up of live cells and a hydrogel scaffold

According to nScrypt: “This project was a step toward bringing next-generation critical care close to the warfighter, which is expected to improve healing and survival rates, reduce expensive and wasteful logistics, warehousing, refrigeration and shipping, and lead to the direct repair or replacement of damaged tissue.”

The ruggedized version of the BioAssembly Tool bioprinter was also recently commercialized. Launched as the nRugged, the system is the first and only existing bioprinting platform for precision manufacturing in harsh environments. The system consists of nScrypt’s Factory in a Tool (FIT) digital manufacturing platform encased in a protective, easily transportable box.

In addition to deploying its bioprinter into the military field, nScrypt also launched a version of its bioprinter into space, to be used aboard the International Space Station (ISS) for printing cardiac patches for damaged hearts. The space-hardened bioprinter integrates the company’s SmartPump technology which has 100 picoliter volumetric control and dispenses materials down to 10 microns.

“When dealing with something as important as tissue, it is vital to place the correct amount of material in the correct position every time,” explained Ken Church, CEO of nScrypt. “This is what our machines offer and what has contributed to our success in bioprinting.”

Polymer AM Market Opportunities and Trends

741 unique polymer AM companies individually surveyed and studied. Core polymer AM market generated $4.6 billion in 2021. Market expected to grow to over $34 billion by 2030 at 24.8% CAGR. This new...

Tess Boissonneault

Tess Boissonneault is a Montreal-based content writer and editor with five years of experience covering the additive manufacturing world. She has a particular interest in amplifying the voices of women working within the industry and is an avid follower of the ever-evolving AM sector. Tess holds a master's degree in Media Studies from the University of Amsterdam.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services